Photo from labs.dana-farber.org ↗Lab page · labs.dana-farber.org ↗

Edward Chouchani

Researcher · Founder

Now Founder, Matchpoint Therapeutics

Latest on AI4S.fyiFunding · Oct 7 · founderMatchpoint Therapeutics · Series B · $150M

Photos come from each person's X account, their own site, lab or team page, a conference page that lists them as a speaker in the same role, or Wikimedia Commons under the licence credited, so some may be out of date. Anyone can ask for theirs to be replaced or removed. Contact →

Affiliations

Current

Founder · Matchpoint Therapeuticssanofiventures.com ↗

Also named in the companies' announcements: Harvard

Current roles come from these dated records, not from the bio below. Each links the page it was read from.

Founded

Matchpoint TherapeuticsDrug discovery · 3 rounds on record · disclosed $250M · Series B $150M
Background: Harvard Medical School and Dana-Farber Cancer Institute (Associate Professor of Cell Biology) (as the company's own announcements put it)
Co-founders: Nathanael Gray, Tinghu Zhang, Jianwei Che
Backed byNextech Invest Norwest Sanofi Ventures Atlas Venture Access Biotechnology

On the timeline

2026-10-07Matchpoint Therapeutics raises a $150M Series B to take its oral covalent T-cell drug MPT-062 into the clinic in 2027

Something wrong or missing on this page? Tell me and it will be fixed or removed. Contact →